CorMedix Inc.
CRMD
$5.89
-$0.21-3.44%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 61.31% | -15.97% | -43.93% | -51.16% | -56.02% |
| Total Depreciation and Amortization | 337.57% | 161.13% | 73.11% | -6.89% | -16.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.96% | 19.21% | 15.38% | 11.10% | 34.20% |
| Change in Net Operating Assets | -1,866.88% | -2,701.31% | -965.27% | -705.43% | 109.15% |
| Cash from Operations | -31.78% | -64.84% | -63.24% | -61.84% | -57.70% |
| Capital Expenditure | 64.62% | -150.81% | -77.65% | -62.59% | -49.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 227.56% | 228.76% | 192.13% | 149.67% | -379.49% |
| Cash from Investing | 224.43% | 225.32% | 188.57% | 146.24% | -359.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -52.58% | -74.49% | 131.71% | 121.39% | 213.52% |
| Repurchase of Common Stock | -45.97% | -19.25% | -19.25% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.93% | -74.79% | 132.88% | 120.05% | 212.41% |
| Foreign Exchange rate Adjustments | -160.71% | -88.27% | -108.11% | 90.63% | 132.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -783.99% | -280.54% | 129.92% | 149.01% | 104.41% |
